Peripheral Stem Cell Transplant Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
This study is ongoing, but not recruiting participants.
Study NCT00004143
Information provided by National Cancer Institute (NCI)
First Received: December 10, 1999
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
